TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NP47924 Cytokine Modulators

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published7
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP47924 Cytokine Modulators". Published status: complete. Published value: Value not published. 7 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
6.9Bids / Report
17.3% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 579 active published awards; 550 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published19 Mar 2025, 09:15 GMT
Last source update19 Mar 2025, 09:15 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-04b34f
What is being bought
Supply of Cytokine Modulators to NHS Scotland.
What changed
From the official release history
  1. Status changed to complete
    19 Mar 2025, 09:15 GMT
  2. Official notice release published
    19 Mar 2025, 09:15 GMT
  3. Submission deadline changed to published date
    19 Mar 2025, 09:15 GMT
  4. Status changed to active
    1 Nov 2024, 13:49 GMT
  5. Official notice release published
    1 Nov 2024, 13:49 GMT
  6. Submission deadline changed to 2 Dec 2024, 12:00 GMT
    1 Nov 2024, 13:49 GMT
  7. Buyer information updated
    1 Nov 2024, 13:49 GMT
Lots and requirements (7)
Published by the contracting authority
  • Lot 1 · #1
    Etanercept
    cancelled
    Published valueNot published
    Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Infliximab IV
    cancelled
    Published valueNot published
    Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Infliximab SC
    cancelled
    Published valueNot published
    Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Methotrexate syringes (25mg/1 ml concentration)
    cancelled
    Published valueNot published
    Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Methotrexate pens (25mg/1ml concentration)
    cancelled
    Published valueNot published
    Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #6
    Methotrexate pens (50mg/1 ml concentration)
    cancelled
    Published valueNot published
    Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 7 · #7
    Methotrexate syringes (50mg/1ml concentration)
    cancelled
    Published valueNot published
    Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    19 Mar 2025, 09:15 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £1,700,000
  10. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £44,300,000
  11. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £5,150,000
  12. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £4,200,000
  13. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £577,000
  14. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £1,000
  15. Contract active
    Signed 29 Jan 2025, 00:00 GMT · £15,000
Commercial outcome and competition
Awards
Biogen Idec Ltd, Pfizer Ltd, Sandoz
Not published · Not published · active
Biogen Idec Ltd, Celltrion Healthcare United Kingdom Limited, Janssen Cilag Limited, Sandoz Ltd
Not published · Not published · active
Accord Healthcare Ltd, medac Pharma LLP
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Accord Healthcare Ltd
Not published · Not published · active
Nordic Pharma Ltd
Not published · Not published · active
Nordic Pharma Ltd
Not published · Not published · active
Contracts
Etanercept
£1,700,000 · signed 29 Jan 2025, 00:00 GMT · active
Infliximab IV
£44,300,000 · signed 29 Jan 2025, 00:00 GMT · active
Methotrexate pens (25mg/1ml concentration)
£5,150,000 · signed 29 Jan 2025, 00:00 GMT · active
Infliximab SC
£4,200,000 · signed 29 Jan 2025, 00:00 GMT · active
Methotrexate syringes (25mg/1 ml concentration)
£577,000 · signed 29 Jan 2025, 00:00 GMT · active
Methotrexate pens (50mg/1 ml concentration)
£1,000 · signed 29 Jan 2025, 00:00 GMT · active
Methotrexate syringes (50mg/1ml concentration)
£15,000 · signed 29 Jan 2025, 00:00 GMT · active
Bid statistics
bids: 3 (lot 1)
electronicBids: 3 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 0 (lot 1)
bids: 4 (lot 2)
electronicBids: 4 (lot 2)
foreignBidsFromEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
smeBids: 0 (lot 2)
bids: 1 (lot 3)
electronicBids: 1 (lot 3)
foreignBidsFromEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
smeBids: 0 (lot 3)
bids: 1 (lot 4)
electronicBids: 1 (lot 4)
foreignBidsFromEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
smeBids: 0 (lot 4)
bids: 1 (lot 5)
electronicBids: 1 (lot 5)
foreignBidsFromEU: 0 (lot 5)
foreignBidsFromNonEU: 0 (lot 5)
smeBids: 0 (lot 5)
bids: 1 (lot 6)
electronicBids: 1 (lot 6)
foreignBidsFromEU: 0 (lot 6)
foreignBidsFromNonEU: 0 (lot 6)
smeBids: 0 (lot 6)
bids: 1 (lot 7)
electronicBids: 1 (lot 7)
foreignBidsFromEU: 0 (lot 7)
foreignBidsFromNonEU: 0 (lot 7)
smeBids: 0 (lot 7)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authority GB-FTS-115937
View buyer profile

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
    buyer
    centralPurchasingBody

    1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    stephanie.mcniven2@nhs.scot
    +44 1312756000

  • Accord Healthcare Ltd
    supplier

    Sage House, 319 Piner Road, North Harrow, UK, HA1 4HF

  • Biogen Idec Ltd
    supplier

    Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,, Maidenhead, UK, SL6 3UD

  • Celltrion Healthcare United Kingdom Limited
    supplier

    1-7 The Switch, Slough, UK, SL1 1QP

  • Janssen Cilag Limited
    supplier

    50-100, Holmers Farm Way, High Wycombe, UK, HP12 4EG

  • Nordic Pharma Ltd
    supplier

    Abbey House, 1650 Arlington Business Park, Theale, Reading, UK, RG7 4SA

  • Pfizer Ltd
    supplier

    Walton Oaks, Dorking Road, Tadworth, UK, KT20 7NS

  • Sandoz
    supplier

    Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, UK, GU15 3YL

  • Sandoz Ltd
    supplier

    Frimley Business Park, Frimley, Camberley, UK, GU16 7SR

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk
    +44 1312252525

  • medac Pharma LLP
    supplier

    Scion House, Innovation Park, Stirling, UK, FK9 4NF
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published